Navigation Links
Peacetime use of radioisotopes at Oak Ridge cited as Chemical Landmark
Date:2/19/2008

The production and distribution of radioactive isotopes for peacetime uses at Oak Ridge National Laboratory (ORNL) will be designated a National Historic Chemical Landmark by the American Chemical Society in a special ceremony in Oak Ridge, Tenn., on March 6.

Bruce E. Bursten, Ph.D., president of the Society, will present a commemorative plaque to Thomas Mason, Ph.D., the director of ORNL. Bursten said the distribution of radioisotopes, which began in 1946, demonstrated the peaceful uses of nuclear energy, providing medical, scientific, and industrial benefits to society. These important activities at ORNL are among those that ultimately led President Eisenhower to make his famous Atoms for Peace speech to the United Nations in 1953. Because of its pivotal role in making nuclear energy a powerful tool for peaceful purposes, ORNL is clearly worthy of a National Historic Chemical Landmark. Bursten is Distinguished Professor of Chemistry and Dean of the College of Arts and Sciences at the University of Tennessee, Knoxville. The University of Tennessee and Battelle jointly manage ORNL for the U.S. Department of Energy.

The American Chemical Society (ACS), the worlds largest scientific society, sponsors the landmarks program. Only 60 chemical landmarks have been recognized nationwide in the fifteen years since the inception of this program. This makes ORNL a site of distinction, for contributions that reach far beyond the boundaries of scientific circles, touching many lives over many decades, said Judy Benham, Ph.D., chair of the ACS Board of Directors.

Clinton Laboratories, now Oak Ridge National Laboratory, was built during World War II as part of the Manhattan Project; it was the site of the worlds first operational nuclear reactor, called the Clinton Pile or the Graphite Reactor. But the end of hostilities in August 1946 left the fate of the lab in doubt as it was not at all clear whether the government would fund peacetime atomic r
'/>"/>

Contact: Charmayne Marsh
c_marsh@acs.org
202-872-4445
American Chemical Society
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
2. Free Book: Critically Acclaimed Book on Anger Management Now Available in Both Unabridged Audio and Print Form Worldwide
3. Bridges to Excellence Launches Medical Home Program
4. Breckenridge Pharmaceutical Settles Paragraph IV Litigation and Receives FDA Approval for its Oxcarbazepine ANDA
5. Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany)
6. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
7. Bridges to Excellence Announces New Implementation Programs for Health Plans and Additions to Board of Directors
8. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
9. Story tips from the Department of Energys Oak Ridge National Laboratory, Nov. 2007
10. The Cambridge Group Names Two New Principals
11. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...RNewswire/ -- Three decades ago, a study revealed ...y children, prompting a switch by U.S. manufacture...e annual meeting of the Radiological Society of No...ll potentially unsafe. ,, "One of the driving f...tion in the U.S. was to eliminate inadvertent swal...
(Date:11/30/2009)..., Nov. 30 Raleigh dentist Robert...ed a new plan to educate the community and patient...,, Through a series of free educational videos ... lead role in educating the public about the benef... sedation dental care educational videos are avail...
(Date:11/30/2009)...f patients who undergo abdominal/pelvic computed t... additional image acquisition resulting in excess,...y presented today at the annual meeting of the Rad... is the responsibility of all physicians who work ...is as low as reasonably achievable without comprom...
(Date:11/29/2009)...ncer in Europe show a steady decline in mortality ...s from all cancers in the European Union (EU) betw...and eight percent in women, with a large drop amon...ished online in the cancer journal, Annals of Onc... found that there was an average 185.2 deaths per ...
(Date:11/29/2009)...cademy of General Dentistry (AGD) announces that A... Mastership Award during the AGD,s commencement ce...to excellence in dental education.,To accomplish ... continuing dental education in the 16 disciplines...nds-on skills and techniques. , ...
Breaking Medicine News(10 mins):Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2Health News:Raleigh Dentist Dr. Robert Williamson to Educate Patients About Sedation Dentistry 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5Health News:Orange County Dentist Honored by The Academy of General Dentistry 2
... they might add to traditional risk factors , ...le of four offbeat biomarkers accurately predicted...a study of older Swedish men, researchers report. ...shed risk factors such as high blood pressure and ...
... Ore., May 14 On Sunday, June 29,2008, West Coast...f,Oregon,s (ALAO) Reach the Bridge Run, Portland,s...ticipants choose their own start times, but must r...the,paved roads of Forest Park., West Coast Bank ...
...y 14 /PRNewswire-FirstCall/ - LMS Medical Systems ...veloper of the CALM(R) patient,safety software sys...ults,for Fiscal 2008 (March 31), which saw a subst...y year over year. For F08,revenue totaled $4.92 mi...
... (OTCBB: IVME; Frankfurt: I7VF), INVERNESS, SCOTL...,successful balance sheet restructuring for IVMD I... commercialize its existing technology platform an...partners for the,Company,s newly developed digital...
...Serves as a One-Stop Resource for Healthcare Profe...careful research,planning and development, Onward ...der specializing in travel nursing jobs and allied...nificant improvements, resulting from extensive us...
...petite Controller, Hits U.S. Market, WAYNE, N.J.,...l of their appetite and eat up to 30 percent less ...dietary supplement that offers the,breakthrough Eu... is poised to help stop weight gain and break the,...
Other Medicine News:Health News:Biomarkers Predict Heart Deaths 2Health News:Biomarkers Predict Heart Deaths 3Health News:LMS Medical Sees Fiscal 2008 Revenue Jump 72% Over F07 - Q4/F08 Revenue Hits New Record 2Health News:IVMD Inc. kicks off new commercialization initiative 2Health News:IVMD Inc. kicks off new commercialization initiative 3Health News:Onward Healthcare Launches Enhanced Website for Travel Healthcare Professionals 2Health News:New Supplement Helps Americans Eat Less Every Day 2
(Date:11/30/2009)... , ATLANTA, Georgi...ge of,Direct Support (CDS), an internet-based curr...d in partnership by MC Strategies/Elsevier and the... Center, announced today that,its second Disabilit...w,available for administrators and learners to use...
(Date:11/29/2009)... , CHICAGO, Nov. 30 Elastograp...n added to breast ultrasound, helps distinguish ca...ing to an ongoing study presented today at the ann...merica (RSNA). ,, When mammography yields suspi... obtain additional information. However, ultrasoun...
(Date:11/29/2009)... , IOWA CITY, Iowa and ST. LOUIS, Nov. 29 /...er of quantitative imaging software for the advanc...al Technologies, a leader in minimally invasive de...nced the companies have signed a definitive agreem... an endobronchial lung navigation and biopsy syste...
Breaking Medicine Technology:Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Elastography Reduces Unnecessary Breast Biopsies 2Elastography Reduces Unnecessary Breast Biopsies 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 2VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 3VIDA Diagnostics and Veran Medical Sign Definitive Agreement for Joint Development of Endobronchial Navigation System 4Police work undermines cardiovascular health comparison to general population shows 50430 1Police work undermines cardiovascular health comparison to general population shows 50430 2Police work undermines cardiovascular health comparison to general population shows 50430 3Caregivers may benefit from adult day care 50428 1Caregivers may benefit from adult day care 50428 2University of Leicester researchers discover new fluorescent silicon nanoparticles 9073 1University of Leicester researchers discover new fluorescent silicon nanoparticles 9073 2
... in Remission at One Year Mainta...ay 21 Results from an,open-label extension study ...nstrate that adult moderate-to-severe Crohn,s pati...long-term clinical remission and clinical,response...day at Digestive,Disease Week(R) (DDW) in San Dieg...
...e Menopause show significant, improvement in vagi...ent symptoms associated with vulvovagi...rmaceuticals today,announced further positive data...ifene tablets) to treat postmenopausal women with ...on associated with menopause. In,January 2008, Qua...
Other Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 2QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy 3
OES BF-3C40 Bronchoscope
...ull-featured bronchofiberscope yet. The BF-3C40's ...0.2mm from the previous model. It also offers bett...s, thanks to the use of extra-fine optical fibers ...by 70 percent. Images are clearer, bigger, and vir...
...e first in a series of bronchofiberscopes with ele...es necessary to meet the demand for expanded bronc...e scope includes a new control section and ergonom.... It also provides a wider field of view, a smalle...
Broncho-Cath® Endobronchial Tube with CPAP System
Medicine Products: